Holen Sie sich die Stockscreener-App
12.57
2.36%
0.29
Eton Pharmaceuticals Inc Aktie (ETON) Neueste Nachrichten
Where are the Opportunities in (ETON) - Stock Traders Daily
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection) - The Manila Times
Eton Pharmaceuticals Acquires Rare Growth Disorder Drug Increlex, Expanding Pediatric Treatment Portfolio - StockTitan
Eton Pharmaceuticals, Inc. completed the acquisition of Increlex® from Ipsen Biopharmaceuticals, Inc. - Marketscreener.com
Eton Pharmaceuticals Announces Positive Results from Clinical Trial for PKU GOLIKE Protein Substitute - Defense World
Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial - The Manila Times
Eton Pharma's PKU GOLIKE Clinical Trial Shows Breakthrough Results in Metabolic Control - StockTitan
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Short Interest Up 32.6% in November - MarketBeat
Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) top owners are retail investors with 58% stake, while 26% is held by institutions - Yahoo Finance
EcoR1 Capital, LLC Increases Stake in Eton Pharmaceuticals Inc. - GuruFocus.com
The Escalator: AstraZeneca, Eton Pharmaceuticals, AltruBio and more - MM+M Online
Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer - GlobeNewswire
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Sees Significant Increase in Short Interest - Defense World
Short Interest in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Expands By 7.6% - MarketBeat
Eton Pharmaceuticals Inc (ETON) Stock Price Down 5.4% on Dec 2 - GuruFocus.com
238,565 Shares in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Acquired by Wasatch Advisors LP - MarketBeat
Eton Pharmaceuticals’ (ETON) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Eton Pharmaceuticals Inc (ETON) Shares Up 4.24% on Nov 29 - GuruFocus.com
Eton PharmaSmall Cap That's Climbing - MSN
HC Wainwright Issues Pessimistic Forecast for ETON Earnings - MarketBeat
Eton acquires US rights to neonatal diabetes treatment from AMMTeK - Pharmaceutical Technology
HC Wainwright Reiterates "Buy" Rating for Eton Pharmaceuticals (NASDAQ:ETON) - MarketBeat
Eton Pharmaceuticals shares target lifted, holds buy on Amglidia acquisition By Investing.com - Investing.com UK
Eton Pharmaceuticals acquires U.S. rights to Amglidia from AMMTeK - Yahoo Finance
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension) - GlobeNewswire
Eton Pharmaceuticals stock soars to all-time high of $11.12 By Investing.com - Investing.com Nigeria
Eton Pharmaceuticals stock soars to all-time high of $11.12 - Investing.com India
Eton Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Eton Pharmaceuticals Inc (ETON) Stock Price Up 4.34% on Nov 19 - GuruFocus.com
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Sees Large Decline in Short Interest - MarketBeat
What Makes Eton Pharmaceuticals (ETON) a Good Fit for 'Trend Investing' - Yahoo Finance
What is HC Wainwright's Estimate for ETON FY2024 Earnings? - MarketBeat
Eton Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
HC Wainwright Has Bearish Estimate for ETON Q1 Earnings - MarketBeat
Investors Appear Satisfied With Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Prospects As Shares Rocket 29% - Simply Wall St
Eton Pharma Stock Soars Over 140% In 2024More Upside Ahead? - RTTNews
Earnings call: Eton Pharmaceuticals reports growth and targets expansion - Investing.com India
Eton Pharmaceuticals (NASDAQ:ETON) Earns Buy Rating from HC Wainwright - MarketBeat
Analyst Expectations For Eton Pharmaceuticals's Future - Benzinga
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q3 2024 Earnings Call Transcript - Insider Monkey
Eton Pharmaceuticals earnings beat by $0.03, revenue topped estimates - Investing.com UK
Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results - The Manila Times
Eton Pharmaceuticals' (NASDAQ:ETON) growing losses don't faze investors as the stock spikes 16% this past week - Simply Wall St
Eton Pharmaceuticals (NASDAQ:ETON) Secures New U.S. Patent for Proprietary Formulation of Hydrocortisone - Defense World
Eton Pharmaceuticals stock hits 52-week high at $9.13 By Investing.com - Investing.com South Africa
Eton Pharmaceuticals stock hits 52-week high at $9.13 - Investing.com
1.61%
1.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):